Curcumin

I take a bunch of supplements, and most of them are of them this-maybe-helps-a-little-bit variety.

The one that I feel makes the most difference is curcumin. It reduces inflammation which means it reduces the severity of almost all my symptoms. I definitely feel the difference if I miss a dose. I take 1000 mg twice daily, which is kinda highish, but my doctor okayed it.

Thanks for explaining. I've tried it in the past but it didn't do much. I have curcumine supplement now, so I will see if this combination works better. I've recently started using amino acids and creatin and that seems to give me a little energy boost already. So, there are still some things to try (after more than 3 years Long hauling ).

The expert discusses the potential of curcumin, a compound found in turmeric, as a treatment for chronic pain and fatigue, including conditions like Long Covid. They emphasize that curcumin has a long history of safe use, which makes it appealing compared to experimental treatments. Turmeric, the spice containing curcumin, has been used for thousands of years in cooking and medicine. The expert highlights that curcumin is the main health-promoting component in turmeric and is being actively studied for its benefits.

The expert discusses curcumin as a potential treatment for chronic pain and fatigue, including symptoms associated with Long Covid. They emphasize the need for clinical trials to confirm its effectiveness but suggest it could be worth trying for individuals experiencing pain and fatigue without other treatment options. The expert recommends taking curcumin daily, such as 500 mg capsules in the morning and evening, for several months to assess its impact. They also caution that curcumin is an isolated compound from turmeric and should not be considered entirely natural.

This paper reviewed existing studies to understand the potential health benefits of curcumin, a compound found in turmeric, particularly in managing cardiometabolic diseases and complications related to SARS-CoV-2 infection, including long COVID. It focused on curcumin's effects on inflammation, oxidative stress, and other risk factors for cardiovascular and metabolic conditions.

The review found that curcumin has demonstrated anti-inflammatory, antioxidant, and other health-promoting effects in various clinical trials. It also highlighted emerging evidence suggesting that curcumin might help prevent or manage complications associated with long COVID, although this area requires further research.

For individuals dealing with long COVID, this paper suggests that curcumin could potentially offer some relief by addressing inflammation and oxidative stress, which are thought to play a role in the condition. It also underscores the importance of a healthy diet that includes natural compounds like curcumin for overall health improvement.

As a systematic review published in a reputable journal, this paper provides a reliable summary of existing research. However, the findings related to long COVID are preliminary and should be interpreted with caution until more targeted studies are conducted.

This study explored the use of nanocurcumin, a nanoparticle form of curcumin, to enhance its stability and effectiveness in reducing inflammation caused by the spike protein of SARS-CoV-2 in lung epithelial cells. Researchers tested nanocurcumin's ability to inhibit inflammatory responses and inflammasome activity in a laboratory setting using A549 lung epithelial cells.

The study found that nanocurcumin significantly reduced the release of inflammatory molecules like IL-6, IL-1β, and IL-18, as well as the expression of inflammatory genes and proteins involved in the NLRP3 inflammasome machinery. Compared to regular curcumin, nanocurcumin showed improved solubility, bioavailability, and anti-inflammatory effects in the tested conditions.

For individuals with long COVID, this research suggests that nanocurcumin could potentially help manage inflammation in the lungs, which is a common issue in post-COVID conditions. It highlights the possibility of using an enhanced form of curcumin to target specific inflammatory pathways linked to long COVID symptoms.

This experimental study was published in a reputable journal, Pharmaceuticals (Basel, Switzerland), and used well-established laboratory methods. However, as it was conducted in vitro (in a lab setting), further research, including clinical trials, is needed to confirm its effectiveness in humans.